In order to better understand the impact of progranulin-driven cancer stem cell propagation, we analyzed the secretomic profile of breast cancer cells treated with progranulin and identified a crosstalk between the progranulin–sortilin axis and IL-6 in different model systems, including a human-based 3D-like growth platform. Here, SORT1 is linked to breast carcinoma.